In a strategic move to expand its presence in the cloud and managed services sector, funds advised by Bregal Unternehmerkapital (Bregal) have successfully acquired Netrics Group, one of Switzerland’s leading providers in this space,
Tags :Jürg Luginbühl
Waterland Private Equity, along with the minority stakeholders of Netrics Holding, has formalized a share purchase agreement for the divestment of all shares in Netrics Group to Bregal Unternehmerkapital, a global private equity firm. Netrics
Vischer acted as legal counsel to Afinum in its investment in Hofstetter PCB, the European provider of printed circuit boards plating and special final finishing services. Together with its prior investment in GS Swiss, Afinum
A group of investors advised by Munich-based Rigeto Unternehmerkapital has acquired prevention-center as an add-on to the Matignon Group. Prevention-center is a leading Swiss provider of cosmetic, medical and aesthetic services in the field of
Private equity investment firm Ardian, together with the management team led by CEO Agim Emruli, is investing in Swiss-based Flowable Holding and its subsidiaries (MFG). Headquartered in Bern, MFG specialises in services, software development and
The German life science and medtech private equity firm SHS Capital has made a EUR 10 million investment in Simulands, a Swiss manufacturer of simulation devices for medical training of cardiovascular interventions. The investment aims to
FairCap, a Germany based entrepreneurial investment company, has acquired Nyco Flexible Packaging, a Switzerland based manufacturer of advanced and sustainable packaging solutions for the food, beverage, household, personal care and healthcare industries, from Clondalkin Group,
A group of investors advised by Rigeto Unternehmerkapital (“Rigeto”) has acquired 100% of the shares in Laser Beauté Med, headquartered in Sion with additional locations in Monthey and Visp. The oldest dermatology clinic in the Swiss
Nautilus, an innovation specialist in home fitness, has entered into a definitive agreement to acquire Zurich based Vay, a company specialising in computer vision and AI technology solutions and the provider of motion detection and
Atlas Antibodies, a global developer of advanced reagents for biomedical research based in Sweden, has agreed to acquire Evitria Group from its shareholders. The transaction closed on August 5, 2021. Vischer advised the sellers on this
